PCN26 PHARMACOECONOMIC ANALYSIS IN SPAIN OF THERAPY WITH ERLOTINIB, DOCETAXEL, PEMETREXED OR BEST SUPPORTIVE CARE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG CANCER WHO HAVE FAILED PREVIOUS CHEMOTHERAPY REGIMENS
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63456-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)63456-0/fulltext
Title :
PCN26 PHARMACOECONOMIC ANALYSIS IN SPAIN OF THERAPY WITH ERLOTINIB, DOCETAXEL, PEMETREXED OR BEST SUPPORTIVE CARE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG CANCER WHO HAVE FAILED PREVIOUS CHEMOTHERAPY REGIMENS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63456-0&doi=10.1016/S1098-3015(10)63456-0
First page :
Section Title :
Open access? :
No
Section Order :
307